0 Комментарии
0 Поделились
415 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Offers
-
Jobs
-
Форумы
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Biomarkers Market Research Report: Market Size, Demand Analysis & Growth ForecastBiomarkers Market Size, Share, Growth Analysis, and Industry Report The Biomarkers Market research report delivers comprehensive insights into market size, growth trends, key drivers, challenges, and emerging opportunities for the period 2026–2035. The study provides an in-depth analysis of the factors influencing market growth, including industry developments, technological...0 Комментарии 0 Поделились 838 Просмотры 0 предпросмотр
-
prostate cancer biomarkers market Achieves Major Growth MilestonesPolaris Market Research has announced the latest report, namely Prostate Cancer Biomarker Market Size, Share, & Industry Analysis Report: By Type (Genetic Biomarkers, Protein Biomarkers, Cell-Based Biomarkers, and Metabolomic Biomarkers), By Application, By End Use, and By Region – Market Forecast, 2025–2034, that examines the overall market condition both now and in the...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
U.S. Biomarkers Market Analysis: Key Trends and Growth ProspectsThe US Biomarkers Market is witnessing significant transformation, shaped by innovation, evolving consumer expectations, regulatory shifts, and global economic trends. Polaris Market Research’s latest report, US Biomarkers Market, offers a holistic view of the market. It examines the market’s structure, growth drivers, competitive landscape, and future potential to provide a...0 Комментарии 0 Поделились 252 Просмотры 0 предпросмотр
-
US Biomarkers Market: Emerging Trends, Innovations & Future Growth OpportunitiesAccording to a new report by Polaris Market Research, the U.S. biomarkers market was valued at USD 25.92 billion in 2024 and is projected to reach USD 106.03 billion by 2034, expanding at a CAGR of 15.16% over the forecast period. Growth is underpinned by rising cancer incidence, growing chronic disease burden, and robust government support for precision-medicine research and...0 Комментарии 0 Поделились 545 Просмотры 0 предпросмотр